Redeye comments on Polygiene Group´s Q1 2025. Polygiene Group delivered positive growth of 18% YoY w...
Enea's net sales rose 7% to SEK214m, beating Redeye Research Estimate (RRe) by 2%, with the network ...
Fiskars Q1 adjusted EBIT of EUR 26.8m came 1% above Modular Finance consensus expectations.
Redeye updates its outlook on Nanologica, continuing to anticipate a considerable sales ramp-up in H...
Redeye initiates coverage of Camurus, a biotech company that made it from start-up to large cap, cur...
Ahead of Taaleri's Q1 report due on 29 April, we revise our estimates to match the new reporting str...
We raise '25e-'27e adj. EBITA by 10-1% on higher margins Low renegotiation risk 2025 and growth upsi...
Redeye is not entirely surprised to see that Absolent has experienced significant headwinds in Q1.
Redeye provides an initial comment on the Q1 2025 report from Serstech.
Volvo delivered a mixed report, with EBIT 12% below Infront consensus.
Adj. EBITA +12% vs. cons, +39% vs. ABGSCe Better margins and guidance to improve conviction in margi...
Redeye comments on Thunderful Group ahead of its Q1 results, due on 15 May.
On April 22nd, Genetic Analysis AS (“Genetic Analysis” or the “Company”) announced that the Company ...
Two divestments and one acquisition announced Net effect: EBITA +4%, margins to increase from 9.
This friday, between 14.00 - 16.00, NextCell Pharma invites investors, analysts, and media to an inv...
